Related Experiment Video
Updated: Jul 8, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
[Oncology for the general practioner--update 2007].
1Departement Innere Medizin, Abteilung Onkologie, Kantonsspital Graubünden, Chur. richard.cathomas@ksgr.ch
Praxis
|January 9, 2008
Summary
This review covers advances in cancer prevention, screening, and novel therapies, including side effects like skin toxicity from epidermal growth factor receptor (EGFR) inhibitors. It also discusses managing chemotherapy side effects and post-treatment patient follow-up.
Area of Science:
- Oncology
- Dermatology
Context:
- Malignant diseases remain a leading cause of mortality in middle-aged individuals.
- Advances in cancer care necessitate updated knowledge on prevention, treatment, and side effect management.
Purpose:
- To review recent developments in cancer prevention and screening.
- To discuss emerging oncological therapeutics and their associated side effects, particularly skin toxicity.
- To outline management strategies for chemotherapy-induced toxicities and post-treatment follow-up.
Summary:
- The article examines current recommendations and innovations in cancer prevention and screening.
- It details novel therapeutic agents used in oncology, highlighting potential side effects such as skin toxicity from epidermal growth factor receptor (EGFR) inhibitors.
- Guidance on managing chemotherapy-induced emesis, diarrhea, and myelosuppression, along with post-discharge follow-up protocols for cancer patients, is provided.
Impact:
- Provides oncologists and healthcare professionals with updated information on cancer management.
- Aims to improve patient outcomes through enhanced prevention, targeted therapies, and proactive side effect management.
- Contributes to the body of knowledge on managing complex cancer treatment toxicities and long-term survivorship care.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...